Mikrobiomin

Mikrobiomin is a term for a multi-strain probiotic supplement intended to support gut microbiota balance and intestinal health. It comprises live microorganisms administered in dietary supplement form.

Typical formulations include several strains from the Lactobacillus and Bifidobacterium genera, and may include Saccharomyces boulardii as a yeast component. Some products use a protective capsule to enhance survivability through stomach acid and may be accompanied by prebiotic fibers such as inulin.

Mechanism and effects are strain-dependent. By increasing the abundance of beneficial microbes, Mikrobiomin can help compete with pathogenic bacteria, contribute to metabolite production such as short-chain fatty acids, and modulate immune responses. The clinical effects can vary among individuals, and these products are not intended as replacements for antibiotic therapy or other medical treatments.

Regulation and safety considerations vary by jurisdiction. Mikrobiomin is typically marketed as a dietary supplement and may be subject to good manufacturing practices and quality controls, rather than conventional drug approvals. Potential side effects are usually mild gastrointestinal symptoms, and such products are generally not recommended for severely immunocompromised individuals or infants without medical advice.

History and research are ongoing. The concept of multi-strain probiotics entered broader consumer markets in the 2010s, and research continues to investigate specific strain combinations for conditions such as irritable bowel syndrome, antibiotic-associated diarrhea, and immune-related outcomes, with results that depend on the product and population studied.